Articles from BIOTECH Patent News (August 1, 2006)

Title	Author	Type	Words
ACell wins extracellular matrix patent battle initiated by Cook Biotech and Purdue.			638
Advanced Research and Technology obtains United States patent.		Brief article	100
AGA Medical files suit in Germany alleging patent infringement.			276
Akesis cites study demonstrating positive clinical effects of chromium/sulfonylurea combination in type 2 diabetes.		Clinical report	409
Arizona Board of Reagents obtains United States patent.			44
Bayer obtains United States patent.			126
BIO-key awarded patents for biometric identification technology.			347
Biogemma obtains United States patent.			138
Biosite and Hopitaux Universitaires de Geneve announce kidney injury collaboration.			456
Carrington subsidiary DelSite granted Chinese patent on GelSite polymer technology for drugs and vaccines.			542
Chemokine announces patent issuance for chemokine analogs for the treatment of human disease.			227
CoGenesys announces worldwide growth factor license agreement with Vegenics.			574
CuraGen and TopoTarget announce Southwest Oncology opens new lymphoma trial with PXD101.			1142
Data confirm durable response of HIV antibody.			882
du Pont obtains United States patent.		Brief article	89
Formulation patent issues for 2ME2 covering diseases characterized by abnormal cell division.			460
InDex obtains United States patent.			103
Introgen presents biomarker data predictive of therapeutic efficacy.			333
Monsanto obtains United States patent.		Brief article	115
Nanogen earns patents for use of biomarkers related to diabetes and Alzheimers Disease.			344
NanoLogix files four patent applications on hydrogen bioreactor methodologies.			505
NanoLogix files three patent applications for hydrogen bioreactor.			290
NanoSensors signs license agreement with MSU.			273
Neurodegenerative disease treatment research receives early-stage funding at Wayne State University investment firm.			325
Nventa signs supply agreement for proprietary adjuvant for use with HspE7.			377
Ohio State University obtains United States patent.		Brief article	60
Patent issues to EntreMed for cancer/arthritis therapeutic.			570
Pioneer Hi-Bred obtains United States patent.			69
Quigley assigned second patent covering peripheral neural and vascular complaints for lead compound QR-333, formulated for diabetic neuropathy.			433
Recombinomics presents data and analysis on pandemic and seasonal influenza evolution at vaccines conference.			363
Ryogen licenses human aminopeptidase P gene patent to OriGene.			360
Sales of biologics to plummet 60% by 2015 as biogeneric competition becomes a reality.			424
Stanford obtains United States patent.		Brief article	90
Strategic partnerships and acquisitions prevail in the rapidly growing specialty pharmaceuticals market.			388
Texas Tech obtains United States patent.			106
United States Department of Health and Human Services obtains United States patent.			115
University of California obtains United States patent.		Brief article	165
Wisconsin Alumni Research Foundation obtains United States patent.			139
Xenomics' patent applications for the diagnosis and monitoring of infectious diseases published.			418